PharmaCyte Biotech ( (PMCB) ) has released a notification of late filing.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
PharmaCyte Biotech, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the fiscal year ending April 30, 2025. The company cited the need for additional time to prepare and review its financial statements to ensure adequate disclosure, which could not be achieved without unreasonable effort and expense. PharmaCyte Biotech expects to file the report no later than 15 days after the original due date of July 29, 2025. The company does not anticipate any significant changes in its financial results compared to the previous fiscal year. The notification was signed by Joshua N. Silverman, the Interim Chief Executive Officer, who assured ongoing compliance efforts.
More about PharmaCyte Biotech
Average Trading Volume: 14,988
Technical Sentiment Signal: Sell
Current Market Cap: $7M
See more data about PMCB stock on TipRanks’ Stock Analysis page.